Illustrative image – not actual.Bio-Rad Laboratories India, the 100 per cent subsidiary of US-based Bio-Rad Laboratories, is planning to set up a plant in Gurgaon, for the manufacture of testing kits for diabetes, thalassemia, HIV and some life science research tools. This decision is in line with the company’s plans to shift its manufacturing facilities from the US to India to enhance its presence in the growing domestic diagnostic test kits’ market.
The plant is likely to be commissioned by the end of 2002. The initial investment in the plant would be $1 million. Some of the critical components for the manufacture of the kits, would be imported. Gradually, the kits would be indigenised.
The products / kits manufactured at this plant would be sold in India and other Asia-Pacific countries.
Bio-Rad also manufactures equipment for blood virus testing, auto-immune disorder testing, haemoglobin screening and HIV testing.
